Chromocell Therapeutics Corporation (CHRO)
NYSEAMERICAN: CHRO · IEX Real-Time Price · USD
1.405
+0.115 (8.91%)
At close: Jul 26, 2024, 1:21 PM
1.460
+0.055 (3.91%)
After-hours: Jul 26, 2024, 6:30 PM EDT
Chromocell Therapeutics Market Cap
Chromocell Therapeutics has a market cap or net worth of $8.42 million as of July 26, 2024.
Market Cap
8.42M
Enterprise Value
4.65M
1-Year Change
n/a
Ranking
Category
Stock Price
$1.41
Market Cap Chart
Since the IPO on February 16, 2024, Chromocell Therapeutics's market cap has decreased from $33.50M to $8.42M, a decrease of -74.87%. That is a compound annual growth rate of -95.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 26, 2024 | 8.40M | -74.93% |
| Feb 16, 2024 | 33.50M | - |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mainz Biomed B.V. | 7.75M |
| Precipio | 7.73M |
| Pulmatrix | 7.71M |
| Predictive Oncology | 7.67M |
| NeuroMetrix | 7.45M |
| iCoreConnect | 7.28M |
| Virpax Pharmaceuticals | 7.27M |
| Bionomics | 7.21M |